← Back to Search

Other

GSK1070806 for Atopic Dermatitis

Phase 1
Waitlist Available
Research Sponsored by GlaxoSmithKline
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to week 24
Awards & highlights

Study Summary

This trial will study how well GSK1070806 works in treating people with atopic dermatitis.

Eligible Conditions
  • Atopic Dermatitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to week 24
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to week 24 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percent change from Baseline in Eczema Area and Severity Index (EASI) at Week 12 in Group 1
Secondary outcome measures
Change from Baseline in EASI at Week 12 in Group 1
Investigator Global Assessment (IGA) Score of 0 or 1 at Week 12 in Group 1
Number of Participants With Positive Anti-drug Antibodies (ADA)- Groups 1 and 2
+4 more

Trial Design

4Treatment groups
Experimental Treatment
Placebo Group
Group I: Group 2: Dupilumab inadequate responders receiving GSK1070806Experimental Treatment1 Intervention
Group II: Group 1: Biologic Naïve participants receiving GSK1070806Experimental Treatment1 Intervention
Group III: Group 1: Biologic Naïve participants receiving PlaceboPlacebo Group1 Intervention
Group IV: Group 2: Dupilumab inadequate responders receiving PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
GSK1070806
2022
Completed Phase 2
~200

Find a Location

Who is running the clinical trial?

GlaxoSmithKlineLead Sponsor
4,755 Previous Clinical Trials
8,070,782 Total Patients Enrolled
GSK Clinical TrialsStudy DirectorGlaxoSmithKline
3,595 Previous Clinical Trials
6,143,896 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must be met to qualify for this research experiment?

"Eligibility for this research protocol requires that participants have eczema, infantile and are between 18-75 years of age. At present, 48 individuals are being sought after to join the trial."

Answered by AI

Has enrollment for this experiment begun yet?

"Contrary to what is outlined on clinicaltrials.gov, this trial does not currently require new participants; the posting was first launched 11/18/2021 and last updated 10/17/2022. However there are 219 additional trials that may be open for recruitment presently."

Answered by AI

Are octogenarians being enrolled for this clinical inquiry?

"According to the eligibility requirements, those hoping to join this medical trial must be between 18 and 75 years old. For patients that are under eighteen or over 65 there are 96 and 153 related clinical trials respectively."

Answered by AI

How widespread is the application of this research?

"At present, 11 medical centres are hosting this trial. Aside from San Antonio, Sugar Land and Miami there are 8 other participating locations that may be closer to you than the initial 3. Choosing a nearby site will reduce your travel needs if enrolled."

Answered by AI

How might GSK1070806 affect an individual's health in the long-term?

"Due to the limited information available, GSK1070806 has been assigned a score of 1 as there is minimal evidence for its safety and efficacy."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis
2021. "Clinical Effect, Safety and Tolerability of GSK1070806 in Atopic Dermatitis". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04975438.
~10 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top